These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 4189147)

  • 41. [Adverse effects of oral contraceptives].
    Adam H; Schirmer B
    Z Arztl Fortbild (Jena); 1973 Nov; 67(21):1078-81. PubMed ID: 4130135
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of ovulation by estrogens.
    Gual C; Becerra C; Rice-Wray E; Goldzieher JW
    Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
    [No Abstract]   [Full Text] [Related]  

  • 43. [Raynaud-like clinical picture during the treatment with an oral contraceptive].
    Ebert H
    Dtsch Gesundheitsw; 1970 Aug; 25(35):1642-3. PubMed ID: 4099005
    [No Abstract]   [Full Text] [Related]  

  • 44. [Menstruation disorders due to Ovosiston medication].
    Kühndel K; Ebeling K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
    [No Abstract]   [Full Text] [Related]  

  • 45. [Problems of the statistical evaluation of clinical studies on oral contraceptives].
    Richter RH; Angst-Horridge A; Arnold M; Mall-Haefeli M; Roth F; Streit-Pfenniger M; Wyss H
    Arch Gynakol; 1969; 207(1):28-30. PubMed ID: 4184750
    [No Abstract]   [Full Text] [Related]  

  • 46. [Porphyria cutanea tarda caused by long-term use of femigen].
    Chowaniec O; Wierzbieta J
    Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Indications for the treatment with sequence preparations].
    Breckwoldt M; Bettendorf G
    Zentralbl Gynakol; 1969 Aug; 91(35):1147-50. PubMed ID: 4189508
    [No Abstract]   [Full Text] [Related]  

  • 48. [Jaundice in intrahepatic cholestasis after ovulation inhibitors].
    Piesbergen H
    Med Welt; 1968 Feb; 9():451-3. PubMed ID: 4181421
    [No Abstract]   [Full Text] [Related]  

  • 49. [Liver function studies under the effect of 4 sequential hormonal contraceptives].
    Brügmann E; Göretzlehner G; Klie E; Schwager A; Maass M
    Z Gesamte Inn Med; 1978 Nov; 33(22):826-9. PubMed ID: 85373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Peroral contraception (5): continuing low dosage treatment].
    Larsson-Cohn U
    Lakartidningen; 1970 Jun; 67():Suppl III:56+. PubMed ID: 4097873
    [No Abstract]   [Full Text] [Related]  

  • 51. [Recurrent jaundice in the course of natural and iatrogenic estrogen metabolism disorders].
    Mach G; Gładysz A
    Pol Tyg Lek; 1979 Dec; 34(49):1923-4. PubMed ID: 94437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral contraceptives.
    Durand RW; Bayston BK
    N Z Med J; 1966 Sep; 65(409):628. PubMed ID: 4162782
    [No Abstract]   [Full Text] [Related]  

  • 53. ["1st experiences with Ovosiston in new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. "Viewpoint concerning works of Chr. Zwahr and H. Geschke].
    Kühne D
    Dtsch Gesundheitsw; 1970 Nov; 25(47):2245-7. PubMed ID: 4100385
    [No Abstract]   [Full Text] [Related]  

  • 54. [Serum immunoglobulins and C-reactive protein following oral administration of ovulation inhibitors].
    Gay S; Seidenschnur G; Geiler G
    Dtsch Gesundheitsw; 1972 Jan; 27(1):32-4. PubMed ID: 4111064
    [No Abstract]   [Full Text] [Related]  

  • 55. [Contraceptives, application and side effects from the dermatological viewpoint].
    Schäfer I
    Dtsch Gesundheitsw; 1971 Feb; 26(9):405-9. PubMed ID: 4104204
    [No Abstract]   [Full Text] [Related]  

  • 56. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

  • 57. Psychosis associated with the use of a sequential oral contraceptive.
    Daly RJ; Kane FJ; Ewing JA
    Lancet; 1967 Aug; 2(7513):444-5. PubMed ID: 4166106
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of oral contraceptives and epsilon-aminocaproic acid on pregnant female rats and their fetuses. Histopathologic study].
    Niznikowska-Marks MJ; Oknińska A; Gawlik Z; Grygalewicz J; Galczak W; Ostojska J
    Patol Pol; 1981; 32(1):37-52. PubMed ID: 6171763
    [No Abstract]   [Full Text] [Related]  

  • 59. [Continuous microdoses of chloramadinone during lactation].
    González C
    Ginecol Obstet Mex; 1970 Nov; 28(169):563-6. PubMed ID: 4100890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
    Mikrut W
    Wiad Lek; 1983 Oct; 36(19):1587-92. PubMed ID: 6198806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.